EWA
LBRX

EverSource Wealth Advisors’s LB Pharmaceuticals LBRX Stock Holding History

EverSource Wealth Advisors’s Portfolio LBRX Stock Details LBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$65 Buy
2
+1
+100% +$29 ﹤0.01% 4336
2026
Q1 		$25 Buy
+1
New +$23 ﹤0.01% 4352

Other funds holding LBRX

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

EverSource Wealth Advisors's LBRX Position: Q2 2026 in Review

EverSource Wealth Advisors increased its LB Pharmaceuticals (LBRX) stake by 100% in Q2 2026, buying an estimated $29 and bringing the position to 2 shares worth $65. The position accounts for ﹤0.01% of the portfolio, ranked #4336.

EverSource Wealth Advisors first reported a position in LBRX in Q1 2026 and has held it in 2 quarters since. 5 funds tracked by Wall St. Rank hold LBRX as of Q2 2026.

  • EverSource Wealth Advisors held 2 shares of LB Pharmaceuticals worth $65 as of Q2 2026.
  • EverSource Wealth Advisors bought 1 LB Pharmaceuticals share in Q2 2026, an estimated $29.
  • LB Pharmaceuticals made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #4336 holding.
  • EverSource Wealth Advisors first reported a position in LB Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 5 funds tracked by Wall St. Rank held LB Pharmaceuticals as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.